Glaukos (GKOS) EPS (Basic) Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.72% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.10% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.43% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.44% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 58.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 26.49% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 5.98% |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn | 22.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.13% |
| Dec 31, 2025 | -52.27% |
| Sep 30, 2025 | 21.55% |
| Jun 30, 2025 | 29.25% |
| Mar 31, 2025 | -69.95% |
| Dec 31, 2024 | -48.21% |
| Sep 30, 2024 | -71.00% |
| Jun 30, 2024 | -38.06% |
| Mar 31, 2024 | -31.57% |
| Dec 31, 2023 | -46.20% |
| Sep 30, 2023 | -21.64% |
| Jun 30, 2023 | 8.92% |
| Mar 31, 2023 | 16.57% |
| Dec 31, 2022 | -39.55% |
| Sep 30, 2022 | -16.17% |
| Jun 30, 2022 | -78.08% |
| Mar 31, 2022 | 68.10% |
| Dec 31, 2021 | 111.05% |
| Sep 30, 2021 | 38.98% |
| Jun 30, 2021 | -36.32% |
| Mar 31, 2021 | -65.10% |
| Dec 31, 2020 | -115.44% |
| Sep 30, 2020 | -120.70% |
| Jun 30, 2020 | -108.01% |
| Mar 31, 2020 | -251.24% |
| Dec 31, 2019 | 57.30% |
| Sep 30, 2019 | -142.91% |
| Jun 30, 2019 | -64.22% |
| Mar 31, 2019 | -49.38% |
| Dec 31, 2018 | 39.49% |
| Sep 30, 2018 | -46.85% |
| Jun 30, 2018 | 76.08% |
| Mar 31, 2018 | 41.52% |
| Dec 31, 2017 | 26.32% |
| Sep 30, 2017 | 27.29% |
| Jun 30, 2017 | 51.93% |
| Mar 31, 2017 | 26.34% |